Johnson & Johnson Development Corporation
venture capital
Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators,...Homepage: http://www.jjdevcorp.com/
HQ
08901 410 George StreetNew Brunswick
USA NJ
Phone: (732) 524-3218
Johnson & Johnson Development Corporation at CrunchBase
April, 2013
Johnson & Johnson Development Corporation invested $18M in Aquinox Pharmaceuticals as a Series C round
March, 2013
Johnson & Johnson Development Corporation invested $48M in Nevro as a Series C round
October, 2012
Johnson & Johnson Development Corporation invested $30M in Genocea Biosciences as a Series C round
June, 2012
Johnson & Johnson Development Corporation invested $40.4M in Astute Medical as a Series C round
Johnson & Johnson Development Corporation invested $23M in PhaseBio Pharmaceuticals as a Series B round
May, 2012
Johnson & Johnson Development Corporation invested $35M in Mitralign as a Series D round
February, 2012
Johnson & Johnson Development Corporation invested $43M in Celladon as unattributed round
November, 2011
Johnson & Johnson Development Corporation invested $95.9M in Biocartis as a Series C round
July, 2011
Johnson & Johnson Development Corporation invested $58M in Nevro as unattributed round
March, 2011
Johnson & Johnson Development Corporation invested $13M in Astute Medical as a Series B round
November, 2010
Johnson & Johnson Development Corporation invested $22M in 23andMe as a Series C round
May, 2010
Johnson & Johnson Development Corporation invested $23M in Breathe Technologies as a Series C round
Johnson & Johnson Development Corporation invested $26.5M in Astute Medical as a Series B round
April, 2010
Johnson & Johnson Development Corporation invested $41.3M in Biocartis as a Series B round
September, 2009
Johnson & Johnson Development Corporation invested $23.7M in Neotract as a Series B round
August, 2009
Johnson & Johnson Development Corporation invested $14.3M in Neurosearch as unattributed round
June, 2009
Johnson & Johnson Development Corporation invested $7.4M in Pronota as a Series B round
Johnson & Johnson Development Corporation invested $21.5M in CoAxia as a Series D round
February, 2009
Johnson & Johnson Development Corporation invested $5.5M in ImaCor as a Series A round
December, 2008
Johnson & Johnson Development Corporation invested $40M in Catalyst Biosciences as a Series C round
October, 2008
Johnson & Johnson Development Corporation invested $60M in Biolex Therapeutics as a Series D round
August, 2007
Johnson & Johnson Development Corporation invested $15.6M in Molecular Partners as a Series A round
July, 2007
Johnson & Johnson Development Corporation invested $25M in Novocell as a Series C round
April, 2007
Johnson & Johnson Development Corporation invested $32M in Metabolex as a Series D round
May, 2006
Johnson & Johnson Development Corporation invested $20M in Novocell as unattributed round
April, 2006
Johnson & Johnson Development Corporation invested $7.8M in Pronota as a Series A round
September, 2005
Johnson & Johnson Development Corporation invested $36M in Biolex Therapeutics as a Series B round
August, 2005
Johnson & Johnson Development Corporation invested $39M in Tengion as a Series A round
January, 2005
Johnson & Johnson Development Corporation invested $8M in Biolex Therapeutics as unattributed round